Growth Metrics

Arcus Biosciences (RCUS) Shares Issued: 2018-2025

Historic Shares Issued for Arcus Biosciences (RCUS) over the last 5 years, with Sep 2025 value amounting to $8.0 million.

  • Arcus Biosciences' Shares Issued was N/A to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $383.0 million, marking a year-over-year change of. This contributed to the annual value of $228.0 million for FY2024, which is 812.00% up from last year.
  • According to the latest figures from Q3 2025, Arcus Biosciences' Shares Issued is $8.0 million, which was down 94.37% from $142.0 million recorded in Q1 2025.
  • In the past 5 years, Arcus Biosciences' Shares Issued ranged from a high of $228.0 million in Q1 2024 and a low of -$235,000 during Q4 2021.
  • Over the past 3 years, Arcus Biosciences' median Shares Issued value was $13.5 million (recorded in 2023), while the average stood at $67.2 million.
  • Over the last 5 years, Arcus Biosciences' Shares Issued had its largest YoY gain of 34,151.17% in 2021, and its largest YoY loss of 204.91% in 2021.
  • Over the past 5 years, Arcus Biosciences' Shares Issued (Quarterly) stood at -$235,000 in 2021, then soared by 2,653.19% to $6.0 million in 2022, then skyrocketed by 66.67% to $5.0 million in 2023, then skyrocketed by 22,700.00% to $228.0 million in 2024, then crashed by 37.72% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $142.0 million for Q1 2025, and $228.0 million during Q1 2024.